| ARYVX | MGLCX | ARYVX / MGLCX | |
| Total Expense Ratio | 1.11 | 1.93 | 58% |
| Annual Report Gross Expense Ratio | 1.11 | 1.94 | 57% |
| Fund Existence | 15 years | 12 years | - |
| Gain YTD | 15.632 | 13.597 | 115% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 1000 | 250% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 835M | 2.24B | 37% |
| Annual Yield % from dividends | 2.73 | 1.88 | 145% |
| Returns for 1 year | 18.68 | 12.82 | 146% |
| Returns for 3 years | 39.03 | 16.60 | 235% |
| Returns for 5 years | 12.37 | -9.19 | -135% |
| Returns for 10 years | 63.23 | 18.12 | 349% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GWGIX | 22.51 | 0.03 | +0.13% |
| AMG GW&K Small Mid Cap Core I | |||
| WEUSX | 15.37 | -0.02 | -0.13% |
| SEI World Equity Ex-US A (SIIT) | |||
| FBTTX | 41.62 | -0.08 | -0.19% |
| Fidelity Advisor Biotechnology M | |||
| FSEBX | 16.96 | -0.04 | -0.24% |
| Fidelity Advisor Sustainable U.S. Eq | |||
| PASIX | 10.49 | -0.03 | -0.29% |
| PACE Alternative Strategies A | |||